NFKB1 and depressive symptom measurement: Antidepressant drugs decrease the activation of NF-κB and MAP kinases in animal models of depression (Obuchowicz et al. 2014; Yang et al. 2014; Roumestan et al. 2007), although there are also negative reports (Martín-Hernández et al. 2018).